|
Real-time Estimate
Cboe BZX
15:16:20 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 806.28 USD | -0.50% |
|
-5.48% | +4.33% |
| Market Cap | 80.91B 69.63B 65.56B 59.74B 112B 7,699B 112B 777B 300B 3,922B 304B 297B 12,426B | P/E 2026 * |
18.8x | P/E 2027 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 74.05B 63.72B 59.99B 54.66B 102B 7,046B 103B 711B 275B 3,590B 278B 272B 11,372B | EV / Sales 2026 * |
4.38x | EV / Sales 2027 * | 3.81x |
| Free-Float |
71.06% | Yield 2026 * |
0.48% | Yield 2027 * | 0.55% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
CBOE
| REGN | Real-time | |
|
Mexican S.E.
| REGN * | End-of-day quote | |
|
Xetra
| RGO | End-of-day quote | |
|
Tradegate
| RGO | Real-time | |
|
Boerse Muenchen
| RGO | Real-time | |
|
Deutsche Boerse AG
| RGO | Delayed | |
|
London S.E.
| 0R2M | Delayed | |
|
Borsa Italiana
| 1REGN | End-of-day quote | |
|
Wiener Boerse
| REGN | End-of-day quote | |
|
Börse Stuttgart
| RGO | Delayed | |
|
Lima
| REGNUS | End-of-day quote |
Last Transcript : Regeneron Pharmaceuticals, Inc.
| 1 day | -0.91% | ||
| 1 week | -5.46% | ||
| Current month | +0.80% | ||
| 1 month | -0.32% | ||
| 3 months | +30.72% | ||
| 6 months | +3.06% | ||
| Current year | +4.35% |
| 1 week | 796.72 |  | 859.34 |
| 1 month | 775.83 | | 859.34 |
| Current year | 591.52 | | 859.34 |
| 1 year | 541 | | 859.34 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 2000-12-31 | |
| Chief Executive Officer | 73 | 1988-01-07 | |
| Director of Finance/CFO | 55 | 2024-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2023-06-08 | |
Michael Brown
BRD | Director/Board Member | 85 | 1991-05-31 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 1991-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/3/26 | Sell | Executive/Senior Manager | -1,131 | 0.0011% | ||
| 9/2/26 | Exercice | Director | 1,200 | 0.0012% | ||
| 8/19/26 | Exercice | General Counsel | 33,583 | 0.0326% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.92% | -5.46% | +44.73% | -3.37% | 80.91B | |
| -2.05% | -0.64% | -19.76% | -36.79% | 60.46B | |
| -2.29% | -9.04% | +460.60% | +29.66% | 56.02B | |
| +0.83% | -4.47% | -8.40% | +30.44% | 49.63B | |
| -1.11% | -7.21% | -2.15% | +148.24% | 45.88B | |
| -0.43% | -5.07% | +47.19% | -18.36% | 31.4B | |
| +2.52% | -1.61% | +48.08% | +96.80% | 25.22B | |
| -2.00% | -3.35% | -2.29% | +177.79% | 22.25B | |
| -3.02% | -2.59% | +60.23% | +99.82% | 16.59B | |
| +0.90% | -7.14% | -23.99% | +726.73% | 14.38B | |
| Average | -0.76% | -1.28% | +60.43% | +125.10% | 40.27B | |
| Weighted average by Cap. | -0.92% | -1.14% | +77.01% | +63.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.92B 14.56B 13.71B 12.49B 23.37B 1,610B 23.46B 162B 62.8B 820B 63.53B 62.15B 2,599B | 18.44B 15.87B 14.94B 13.62B 25.48B 1,755B 25.58B 177B 68.45B 894B 69.25B 67.75B 2,832B |
| Net income | 4.77B 4.11B 3.87B 3.52B 6.59B 454B 6.62B 45.84B 17.72B 231B 17.92B 17.53B 733B | 5.45B 4.69B 4.41B 4.02B 7.52B 518B 7.55B 52.29B 20.21B 264B 20.45B 20B 836B |
| Net Debt | -6.87B -5.91B -5.57B -5.07B -9.49B -654B -9.53B -65.96B -25.49B -333B -25.79B -25.23B -1,055B | -10.55B -9.08B -8.55B -7.79B -14.58B -1,004B -14.64B -101B -39.17B -512B -39.63B -38.77B -1,621B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | US$805.15 | -0.64% | 288,482 |
| 26-09-08 | US$810.31 | -2.10% | 556,536 |
| 26-09-04 | US$827.72 | -1.87% | 561,170 |
| 26-09-03 | US$843.47 | -1.00% | 496,255 |
| 26-09-02 | US$852.03 | +3.42% | 749,453 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
